Search Results 421-430 of 25787 for anti-aging research
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Rituximab, an anti-CD20 chimeric antibody, was approved by the United States Food and Drug Administration in 1998 for the treatment of patients with relapsed ...
Latest stories · Research · Driven by family, fueled by hope: Mayo Clinic researcher fights against Type 1 diabetes · Science Saturday: Progressive alliance ...
Research provides critical information about the size and growth speed of gliomas. Kelley Luckstein. October 7, 2022. Aging. Taking a Closer Look at Menopausal ...
Aging · AI and Digital Health · Biotherapeutics ... This eventually developed into what is known today as the anti-G straining maneuver, nicknamed "the grunt.
Safety and Efficacy of ALLO-605 an Anti-BCMA ... Participant eligibility includes age, gender ... Research Faculty · Laboratories · Core Facilities ...
JACKSONVILLE, Fla. — Mayo Clinic's pioneering exploration of stem cell-based therapies for bone loss is headed to space. Abba Zubair, M.D., Ph.D., ...
Researchers discover an aging and inflammation biomarker featured image. Research. Researchers discover an aging and inflammation biomarker. Alison Satake.
The purpose of this study is to explore lay understandings toward participating in and perceptions of consent to biospecimen research and valuation of genetics ...
The Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) Trial will compare the relative efficacy and safety of intravitreal methotrexate ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.